NASDAQ NMS - GLOBAL MARKET · CAMP
-4.48% · -$0.2000 · Vol 126.9K
Market closed · last close 4:00 PM ET · price as of 18:40:32 ET
CAMP4 Therapeutics Corp

CAMP4 Therapeutics Corp

Biotechnology
$4.26
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
CAMP
CAMP4 Therapeutics Corp
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

29/ 100
Veridion Score
AVOID · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CAMP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CAMP catalysts
About CAMP4 Therapeutics Corp
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
48
Country
US

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.50
Day high
$4.54
Day low
$4.42
Previous close
$4.46
52W high
$7.13
-40.25% from high
52W low
$1.41
50% of range
Market cap
$281.1M
EPS
$-2.0700
Beta
0.78
Shares out
62.8M
Volume
126.9K
0.59× rel vol
Avg volume
215.2K
VWAP
$4.49
Price history computed in-house
1W
-21.69%
1M
+34.81%
3M
-5.54%
1Y
+174.84%
YTD
-30.51%
SMA 50 $4.11 · above
SMA 200 $4.48 · below
52W position 50%

CAMP overview

Veridion Score
29
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CAMP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CAMP Form 4 filings
Public disclosures

Congress activity in CAMP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CAMP in the cached public ledger.

Federal contracts

CAMP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CAMP in this window.
Lobbying spend

CAMP lobbying filings, year to date.

Registered lobbying filings matched to CAMP4 Therapeutics Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CAMP in this window.
Loading news for CAMP
Analyst ratings
Sovereign unlock shows live analyst consensus for CAMP.
Options
Sovereign unlock shows live options positioning for CAMP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.